Pictet Asset Management (UK)’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Pictet Asset Management (UK)’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-48,824	Closed	-$2.63M	–	919
2017 Q4	$2.63M	Buy	48,824 +9,800	+25%	+$536K	0.01%	777
2017 Q3	$2.23M	Sell	39,024 -85,524	-69%	-$5.01M	0.01%	778
2017 Q2	$6.86M	Sell	124,548 -61,877	-33%	-$3.52M	0.02%	553
2017 Q1	$10.2M	Buy	+186,425	New	+$9.18M	0.03%	472

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Pictet Asset Management (UK)'s BIVV Position: Q1 2018 in Review

Pictet Asset Management (UK) sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 48,824 shares — an estimated $2.63M sold.

Pictet Asset Management (UK) first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $10.2M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Pictet Asset Management (UK) reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Pictet Asset Management (UK) sold 48,824 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2.63M.
Pictet Asset Management (UK) first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Pictet Asset Management (UK)'s Bioverativ Inc. Common Stock position peaked at $10.2M in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2018, filed 25 Apr 2018.